|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/444 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1915151 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06739398.3 |
| Europos patento paraiškos padavimo data | 2006-03-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-04-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-08-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/010582 |
| Data | 2006-03-22 |
| (87) | Numeris | WO 2006/102504 |
| Data | 2006-09-28 |
| (30) | Numeris | Data | Šalis |
| 664381 P | 2005-03-22 | US |
| (72) |
CHANG, David, US
|
| (73) |
Amgen, Inc,
Patent Operations, M/S 28-2-C One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS |
| COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS |